• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Role for digoxin in patients hospitalized with COVID-19 and atrial arrhythmias.

作者信息

Peltzer Bradley, Lerman Bruce B, Goyal Parag, Cheung Jim W

机构信息

Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York Presbyterian Hospital, New York, New York, USA.

出版信息

J Cardiovasc Electrophysiol. 2021 Mar;32(3):880-881. doi: 10.1111/jce.14901. Epub 2021 Feb 1.

DOI:10.1111/jce.14901
PMID:33522631
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8013385/
Abstract
摘要

相似文献

1
Role for digoxin in patients hospitalized with COVID-19 and atrial arrhythmias.地高辛在新冠病毒病合并房性心律失常住院患者中的作用。
J Cardiovasc Electrophysiol. 2021 Mar;32(3):880-881. doi: 10.1111/jce.14901. Epub 2021 Feb 1.
2
Atrial fibrillation and flutter in patients hospitalized for COVID-19: The challenging role of digoxin.因新型冠状病毒肺炎住院患者的心房颤动和心房扑动：地高辛的挑战性作用。
J Cardiovasc Electrophysiol. 2021 Mar;32(3):878-879. doi: 10.1111/jce.14894. Epub 2021 Feb 1.
3
Atrial Arrhythmias in a Patient Presenting With Coronavirus Disease-2019 (COVID-19) Infection.一名新型冠状病毒肺炎（COVID-19）感染患者的房性心律失常
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620925571. doi: 10.1177/2324709620925571.
4
Hyperthyroid-induced atrial flutter-fibrillation with profound sinoatrial nodal pauses due to small doses of digoxin, verapamil, and propranolol.小剂量地高辛、维拉帕米和普萘洛尔导致甲状腺功能亢进诱发的心房扑动-颤动并伴有严重的窦房结停搏。
Clin Cardiol. 1989 Jan;12(1):45-7. doi: 10.1002/clc.4960120109.
5
Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.地高辛治疗心房颤动和心房扑动：随机临床试验的系统评价与荟萃分析和试验序贯分析。
PLoS One. 2018 Mar 8;13(3):e0193924. doi: 10.1371/journal.pone.0193924. eCollection 2018.
6
[Two unusual phenomena observed after brief treatment with moderate doses of digoxin: escape-capture bigeminy; vertigo due to auricular and ventricular arrest in the course of paroxysmal auricular fibrillation].[中等剂量地高辛短期治疗后观察到的两种异常现象：逸搏夺获二联律；阵发性心房颤动过程中因心房和心室停搏所致眩晕]
Boll Soc Ital Cardiol. 1966;11(4):1054-65.
7
Impact of the coronavirus disease 2019 pandemic on atrial fibrillation and atrial flutter ablation rates. The analysis of nearly 5 million Polish population.
Kardiol Pol. 2021;79(6):687-689. doi: 10.33963/KP.15988. Epub 2021 May 20.
8
[Treatment with maintenance dose of digoxin; an analysis of 102 cases].
Zhonghua Xin Xue Guan Bing Za Zhi. 1980 Mar;8(1):20-2.
9
Left Atrial Function in Patients with Coronavirus Disease 2019 and Its Association with Incident Atrial Fibrillation/Flutter.2019冠状病毒病患者的左心房功能及其与新发心房颤动/扑动的关联
J Am Soc Echocardiogr. 2021 Oct;34(10):1106-1109. doi: 10.1016/j.echo.2021.05.015. Epub 2021 May 31.
10
Atrial flutter or atrial fibrillation?心房扑动还是心房颤动？
Hosp Pract (1995). 1995 Aug 15;30(8):17-8. doi: 10.1080/21548331.1995.11443234.

引用本文的文献

1
Bioinformatics-based investigation on the genetic influence between SARS-CoV-2 infections and idiopathic pulmonary fibrosis (IPF) diseases, and drug repurposing.基于生物信息学的 SARS-CoV-2 感染与特发性肺纤维化（IPF）疾病之间遗传影响的研究，以及药物再利用。
Sci Rep. 2023 Mar 22;13(1):4685. doi: 10.1038/s41598-023-31276-6.
2
Identification of host genomic biomarkers from multiple transcriptomics datasets for diagnosis and therapies of SARS-CoV-2 infections.从多个转录组学数据集鉴定宿主基因组生物标志物，用于 SARS-CoV-2 感染的诊断和治疗。
PLoS One. 2023 Mar 13;18(3):e0281981. doi: 10.1371/journal.pone.0281981. eCollection 2023.
3
Meta-Data Analysis to Explore the Hub of the Hub-Genes That Influence SARS-CoV-2 Infections Highlighting Their Pathogenetic Processes and Drugs Repurposing.元数据分析以探索影响SARS-CoV-2感染的枢纽基因的核心，突出其发病机制和药物再利用。
Vaccines (Basel). 2022 Aug 3;10(8):1248. doi: 10.3390/vaccines10081248.

本文引用的文献

1
Atrial fibrillation and flutter in patients hospitalized for COVID-19: The challenging role of digoxin.因新型冠状病毒肺炎住院患者的心房颤动和心房扑动：地高辛的挑战性作用。
J Cardiovasc Electrophysiol. 2021 Mar;32(3):878-879. doi: 10.1111/jce.14894. Epub 2021 Feb 1.
2
Classical Drug Digitoxin Inhibits Influenza Cytokine Storm, With Implications for Covid-19 Therapy.经典药物地高辛抑制流感细胞因子风暴，这对新冠病毒治疗具有启示意义。
In Vivo. 2020 Nov-Dec;34(6):3723-3730. doi: 10.21873/invivo.12221.
3
Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19.与 COVID-19 住院患者的心房心律失常相关的结局和死亡率。
J Cardiovasc Electrophysiol. 2020 Dec;31(12):3077-3085. doi: 10.1111/jce.14770. Epub 2020 Oct 14.
4
Antiviral activity of digoxin and ouabain against SARS-CoV-2 infection and its implication for COVID-19.地高辛和哇巴因抗 SARS-CoV-2 感染的抗病毒活性及其对 COVID-19 的意义。
Sci Rep. 2020 Oct 1;10(1):16200. doi: 10.1038/s41598-020-72879-7.
5
Meta-Analysis of Effects of Digoxin on Survival in Patients with Atrial Fibrillation or Heart Failure: An Update.洋地黄对心房颤动或心力衰竭患者生存影响的荟萃分析：更新。
Am J Cardiol. 2019 Jan 1;123(1):69-74. doi: 10.1016/j.amjcard.2018.09.036. Epub 2018 Oct 4.
6
ATP1A1-mediated Src signaling inhibits coronavirus entry into host cells.ATP1A1介导的Src信号传导抑制冠状病毒进入宿主细胞。
J Virol. 2015 Apr;89(8):4434-48. doi: 10.1128/JVI.03274-14. Epub 2015 Feb 4.
7
Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study.当代房颤患者中与地高辛相关的死亡率增加：TREAT-AF研究的结果
J Am Coll Cardiol. 2014 Aug 19;64(7):660-8. doi: 10.1016/j.jacc.2014.03.060.